Facebook
Twitter
LinkedIn
Forward- DANIELLE HEPTING
- Esther Schulman
- Anna Bakken
Series Overview
This case conference series involves fellows presenting cases of patients with gastroenterology and hepatology diseases and discussion. A case conference is immediately followed by a grand round or a journal club..
Target Audience
UW Clinicians/staff: MDs, DOs, and other members of the GI and Hepatology Care Team and possibly RNs, PAs, and students primarily in the specialties of Gastroenterology, Hepatology, as well as related disciplines such as Oncology, Surgery, Radiology, and Pathology
Planning Committee
| Kerstin Austin, MD, Chair | Rita German, MD, Chair | Danielle Hepting/Esther Schulman, Interim Coordinators |
Accreditation
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee
Disclosures for Planning Committee - March 1, 2022 to June 30, 2022
As a result of participation in this educational series, learners will:
- Increase ability to apply comprehensive knowledge of new and/or developing research , technology, and clinical practice guidelines to provide care for patients with conditions of the digestive system and the liver
- Enhance competence in using a multidisciplinary approach in the management of complex gastroenterology and hepatology diseases.
- Improve practice performance by adopting new technologies, procedures, and best practices in the gastroenterology and hepatology field into routine clinical practice.
